Aerska
Biotechnology Research • • 11-20 Employees
Company overview
| Headquarters | XX |
| Website | |
| NAICS | 541714 |
| Employees | 11-20 |
Key Contacts at Aerska
Jack O'Meara
Ceo, Co-Founder
Stuart Milstein
Co-Founder
Duygu Yilmaz
Director Rna Therapeutics And Translational Science
Alycia Shoultz
Director, Cns Delivery Innovation
Andrew Cregan
Director, Head Of Finance And Administration
Aerska Email Formats
Aerska uses 1 email format. The most common is {first name} (e.g., john@dogpatchlabs.com), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name} | john@dogpatchlabs.com | 100% |
About Aerska
Aerska is a biotechnology company developing RNA medicines to treat, delay, and prevent diseases of the brain. The company is leveraging advances in ‘brain shuttles’ to enable targeted delivery of next-generation RNAi therapeutics to the CNS. Aerska is headquartered in Dublin, Ireland, with research operations in London, UK.
Aerska revenue & valuation
| Annual revenue | $1,112,215 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $3,600,000 |
| Total funding | $21,000,000 |
Employees by Management Level
Total employees: 11-20
Seniority
Employees
Employees by Department
Aerska has 6 employees across 5 departments.
Departments
Number of employees
Spain
Belgium
Italy
South Africa
Germany
Frequently asked questions
4.8
40,000 users
